Company page

Pds Biotechnology Corporation

PDS Biotechnology Corporation, trading under the ticker PDSB, is a public company based in the United States with a market capitalization of approximately $38.1 million. The company focuses on developing innovative therapies for cancer and infectious diseases. PDS Biotechnology aims to advance its proprietary technology to improve patient outcomes in the healthcare sector.